Skip to content

Ansa Biotechnologies

YC W20 · Active · Next-generation DNA synthesis using enzymes

Competitors

Adjacent

Also from W20

All of W20

About Ansa Biotechnologies

Ansa Biotechnologies is developing a new way to make DNA that will be faster, cleaner, and more accurate than existing methods. Currently, DNA is manufactured via a chemical method that has remained mostly unchanged for 35 years. Our enzyme-based approach promises to dramatically accelerate innovation in biological research and biotechnology, including therapeutics, diagnostics and biomanufacturing.

YC batch
W20 · Winter 2020
Status, per YC
Active
Category
Other
Team size
72
Location
San Francisco, CA, USA; Emeryville, CA, USA
Checked
35m ago

YC tags: Synthetic Biology, Biotech

Ansa Biotechnologies in W20: 228 companies, 29% AI

Ansa Biotechnologies: questions

Which YC batch was Ansa Biotechnologies in?

Ansa Biotechnologies was in Y Combinator's Winter 2020 batch (W20).

Is Ansa Biotechnologies still active?

Y Combinator lists Ansa Biotechnologies as active.

Where is Ansa Biotechnologies based?

Ansa Biotechnologies lists San Francisco, CA, USA; Emeryville, CA, USA as its location on YC's directory.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.